Table 5.

Adjusted ^† associations of glucose and triglyceride excursions (of 25 mg/dL) with clinical outcomes (n = 898)

Glucose excursion	Model	Global			Obese (n=375)			Non-obese (n=523)			Interaction ‡
		OR	95% CI	p	OR	95% CI	p	OR	95% CI	p	p
Any cardiovascular complication	1	1.15	(1.06-1.25)	<0.01	1.19	(1.01-1.39)	0.04	1.15	(1.03-1.27)	0.01	0.86
	2	1.06	(0.95-1.17)	0.32	1.12	(0.92-1.36)	0.26	1.03	(0.89-1.19)	0.94	0.35
Heart disease	1	1.13	(1.03-1.25)	0.01	1.22	(1.03-1.46)	0.02	1.10	(0.98-1.25)	0.11	0.38
	2	1.04	(0.91-1.18)	0.57	1.20	(0.96-1.50)	0.12	0.96	(0.82-1.14)	0.65	0.11
Myocardial infarction	1	1.21	(1.06-1.38)	<0.01	1.32	(1.03-1.68)	0.03	1.17	(1.00-1.36)	0.05	0.42
Angina	1	1.11	(0.99-1.25)	0.09	1.21	(0.99-1.48)	0.06	1.07	(0.92-1.25)	0.41	0.36
Stroke	1	1.23	(1.02-1.48)	0.03	1.08	(0.63-1.84)	0.78	1.25	(1.-1.47)	0.05	0.50
Heart failure	1	1.15	(1.00-1.33)	0.06	1.19	(0.93-1.52)	0.16	1.15	(0.95-1.38)	0.15	0.90
Triglyceride excursion		Global			Obese (n=375)			Non-obese (n=523)			Interaction ‡
		OR	95% CI	p	OR	95% CI	p	OR	95% CI	p	p
Any cardiovascular complication	1	1.00	(0.90-1.12)	0.94	1.11	(0.91-1.35)	0.32	0.93	(0.81-1.08)	0.34	0.15
	2	1.01	(0.90-1.13)	0.87	1.15	(0.93-1.43)	0.20	0.91	(0.78-1.06)	0.21	0.06
Heart disease	1	1.02	(0.89-1.16)	0.80	1.23	(0.96-1.58)	0.10	0.91	(0.78-1.07)	0.24	0.04
	2	1.02	(0.90-1.17)	0.72	1.25	(0.95-1.63)	0.11	0.91	(0.77-1.07)	0.24	0.04
Myocardial infarction	1	1.07	(0.87-1.32)	0.52	1.12	(0.79-1.59)	0.53	1.05	(0.80-1.36)	0.73	0.79
Angina	1	1.01	(0.85-1.19)	0.93	1.36	(1.01-1.83)	0.04	0.86	(0.72-1.02)	0.09	0.01
Stroke	1	0.96	(0.76-1.21)	0.75	0.89	(0.64-1.24)	0.49	0.98	(0.72-1.33)	0.92	0.76
Heart failure	1	1.03	(0.84-1.27)	0.76	1.09	(0.79-1.49)	0.60	0.97	(0.75-1.26)	0.84	0.56

ELSA-Brasil, 2008–2010.

^†Through logistic regression, as follows:

Model 1: age.

Model 2: model 1 + sex, glycated hemoglobin, duration of diabetes, use of insulin.

^‡Excursion versus obesity interaction.